Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-05 20:14:19 ET
Illumina, Inc. (ILMN) Q4 2025 Earnings Call February 5, 2026 4:30 PM EST
Company Participants
Conor Noel McNamara - VP of Investor Relations
Jacob Thaysen - CEO, Interim Chief Commercial Officer & Director
Ankur Dhingra - Chief Financial Officer
...
Read the full article on Seeking Alpha
For further details see:
Illumina, Inc. (ILMN) Q4 2025 Earnings Call Transcript
Illumina Inc.
NASDAQ: ILMN
ILMN Trading
-1.2% G/L:
$122.73 Last:
452,105 Volume:
$124.32 Open:
ILMN Latest News
March 05, 2026 09:15:00 am
Alliance for Genomic Discovery expands with Regeneron Genetics Center membership and new proteomics data offering
February 27, 2026 09:15:00 am
Illumina whole-genome sequencing technology to accelerate rare disease testing in Florida
February 25, 2026 09:15:00 am
Illumina partners go beyond the genome, driving cancer breakthroughs using spatial transcriptomics, epigenomics, and proteomics
February 24, 2026 12:15:00 pm
Illumina launches TruPath Genome, setting a new standard in genomic insight
ILMN Stock Data
$18,085,408,000
148,827,200
0.13%
404
N/A
Biotechnology & Life Sciences
Healthcare
US
San Diego
